SMTL ID : 6nwv.1

Insulin Lispro Analog

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

hetero-6-6-mer

Ligands

7 x CRS: M-CRESOL(Non-covalent)

CRS.1: 9 residues within 4Å: Chain A: C.6, S.9, I.10, C.11, L.16 Chain B: L.11, A.14 Chain D: H.5 Chain F: L.17 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:I.10, B:L.11 CRS.3: 13 residues within 4Å: Chain C: C.6, S.9, I.10, C.11, L.16 Chain D: C.7, H.10, L.11, A.14 Chain J: L.17 Chain L: V.2, H.5, L.6 6 PLIP interactions: 1 interactions with chain C, 3 interactions with chain L, 2 interactions with chain D Water bridges: C:C.11, L:H.5 Hydrophobic interactions: L:V.2, L:L.6, D:H.10, D:L.11 CRS.5: 13 residues within 4Å: Chain B: L.17 Chain E: C.6, S.9, I.10, C.11, L.16 Chain F: C.7, H.10, L.11, A.14 Chain H: V.2, H.5, L.6 6 PLIP interactions: 2 interactions with chain F, 1 interactions with chain E, 3 interactions with chain H Hydrophobic interactions: F:H.10, F:L.11, H:V.2, H:L.6 Water bridges: E:C.11, H:H.5 CRS.8: 11 residues within 4Å: Chain G: C.6, S.9, I.10, C.11, L.16 Chain H: H.10, L.11, A.14 Chain J: H.5, L.6 Chain L: L.17 4 PLIP interactions: 2 interactions with chain J, 2 interactions with chain H Hydrophobic interactions: J:L.6, H:H.10, H:L.11 pi-Stacking: J:H.5 CRS.9: 5 residues within 4Å: Chain G: L.13, Y.14 Chain K: L.13, Y.14, E.17 7 PLIP interactions: 4 interactions with chain K, 3 interactions with chain G Hydrophobic interactions: K:L.13, K:L.13, K:Y.14, G:L.13, G:Y.14, G:Y.14 Hydrogen bonds: K:E.17 CRS.10: 9 residues within 4Å: Chain D: L.17 Chain F: H.5 Chain I: C.6, S.9, I.10, C.11, L.16 Chain J: L.11, A.14 3 PLIP interactions: 1 interactions with chain J, 1 interactions with chain I, 1 interactions with chain F Hydrophobic interactions: J:L.11, I:I.10 pi-Cation interactions: F:H.5 CRS.12: 9 residues within 4Å: Chain B: H.5 Chain H: L.17 Chain K: C.6, S.9, I.10, C.11, L.16 Chain L: L.11, A.14 1 PLIP interactions: 1 interactions with chain L Hydrophobic interactions: L:L.11

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain B: H.10 Chain D: H.10 Chain L: H.10 Ligands: CL.13 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain L, 1 interactions with chain D Metal complexes: B:H.10, L:H.10, D:H.10 ZN.6: 4 residues within 4Å: Chain F: H.10 Chain H: H.10 Chain J: H.10 Ligands: CL.11 3 PLIP interactions: 1 interactions with chain F, 1 interactions with chain H, 1 interactions with chain J Metal complexes: F:H.10, H:H.10, J:H.10

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 6 residues within 4Å: Chain C: C.7 Chain D: N.3, C.7 Chain L: V.2, N.3, L.6 2 PLIP interactions: 1 interactions with chain D, 1 interactions with chain B Water bridges: D:N.3, B:N.3 GOL.7: 8 residues within 4Å: Chain A: I.10, C.11, S.12 Chain D: H.5, K.28 Chain F: Y.16, L.17, G.20 2 PLIP interactions: 1 interactions with chain F, 1 interactions with chain A Hydrogen bonds: F:G.20, A:C.11

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.11: 6 residues within 4Å: Chain F: L.6, H.10 Chain H: H.10 Chain J: L.6, H.10 Ligands: ZN.6 Ligand excluded by PLIP CL.13: 6 residues within 4Å: Chain B: L.6, H.10 Chain D: L.6, H.10 Chain L: H.10 Ligands: ZN.2 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cruz-Rangel, A. et al., Crystal structure of Lispro hexameric insulin analog. To Be Published

Release Date

2020-02-12

Peptides

Insulin A chain: ACEGIK
Insulin Lispro B chain: BDFHJL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

E
E

G
G

I
I

K
K

B
B

D
D

F
F

H
H

J
J

L
L

Insulin A chain

Insulin Lispro B chain

Related Entries With Identical Sequence